Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans

Diabetologia

Volumn 49, Issue 6, 2006, Pages 1371-1379

  Xiao, C ^a   Giacca, A ^a   Carpentier, A ^b   Lewis, G F ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Insulin clearance; Insulin resistance; Insulin secretion; Lipotoxicity; NEFAs; Non esterified fatty acids; Oral fat ingestion

Indexed keywords

GLUCOSE; INSULIN; LIPID EMULSION; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; WATER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; HUMAN; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN INFUSION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADULT; DIETARY FATS, UNSATURATED; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; GLUCOSE; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT;

EID: 33646533329     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0211-x     Document Type: Article

References (47)

1. Taylor SI, Accili D, Imai Y (1994) Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43:735-740
2. DeFronzo RA (1992) Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389-397
3. Porte D Jr (1991) Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes 40:166-180
4. Polonsky KS (1995) Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research. Diabetes 44:705-717
5. Stein DT, Esser V, Stevenson BE et al (1996) Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735
6. Grill V, Qvigstad E (2000) Fatty acids and insulin secretion. Br J Nutr 83 (Suppl 1):S79-S84
7. Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23:201-229
8. Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461-2474
9. Prentki M, Joly E, El Assaad W, Roduit R (2002) Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 51 (Suppl 3):S405-S413
10. Stein DT, Stevenson BE, Chester MW et al (1997) The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100:398-403
11. Beysen C, Karpe F, Fielding BA, Clark A, Levy JC, Frayn KN (2002) Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 45:1533-1541
12. Brubaker PL, Anini Y (2003) Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 81:1005-1012
13. Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF (2000) Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 49:399-408
14. American Diabetes Association (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27:S5-S10
15. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF (1999) Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055-E1066
16. Lookene A, Skottova N, Olivecrona G (1994) Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat). Eur J Biochem 222:395-403
17. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
18. Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377
19. de Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME (2002) Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr 21:219-223
20. Boden G, Chen X, Rosner J, Barton M (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239-1242
21. Carpentier A, Giacca A, Lewis GF (2001) Effect of increased plasma non-esterified fatty acids (NEFA) on arginine-stimulated insulin secretion in obese humans. Diabetologia 44:1989-1997
22. Carpentier A, Zinman B, Leung N et al (2003) Free fatty acid-mediated impairment of glucose-stimulated insulin secretion in nondiabetic Oji-Cree individuals from the Sandy Lake community of Ontario, Canada: a population at very high risk for developing type 2 diabetes. Diabetes 52:1485-1495
23. Leung N, Sakaue T, Carpentier A, Uffelman K, Giacca A, Lewis GF (2004) Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia 47:204-213
24. Frankenfield D, Roth-Yousey L, Compher C (2005) Comparison of predictive equations for resting metabolic rate in healthy nonobese and obese adults: a systematic review. J Am Diet Assoc 105:775-789
25. Carpentier A, Patterson BW, Leung N, Lewis GF (2002) Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Diabetes 51:1867-1875
26. Carpentier AC, Frisch F, Cyr D et al (2005) On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am J Physiol Endocrinol Metab 289:E849-E856
27. Warnotte C, Nenquin M, Henquin JC (1999) Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion. Mol Cell Endocrinol 153:147-153
28. Zhou YP, Grill VE (1994) Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876
29. Brun T, Assimacopoulos-Jeannet F, Corkey BE, Prentki M (1997) Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46:393-400
30. Mason TM, Goh T, Tchipashvili V et al (1999) Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48:524-530
31. Dobbins RL, Szczepaniak LS, Myhill J et al (2002) The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 51:1825-1833
32. Luan J, Browne PO, Harding AH et al (2001) Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 50:686-689
33. Lin Q, Ruuska SE, Shaw NS, Dong D, Noy N (1999) Ligand selectivity of the peroxisome proliferator-activated receptor alpha. Biochemistry 38:185-190
34. Warnotte C, Nenquin M, Henquin JC (1999) Unbound rather than total concentration and saturation rather than unsaturation determine the potency of fatty acids on insulin secretion. Mol Cell Endocrinol 153:147-153
35. Chan CB, MacDonald PE, Saleh MC, Johns DC, Marban E, Wheeler MB (1999) Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 48:1482-1486
36. Pamplona R, Portero-Otin M, Riba D et al (1998) Mitochondrial membrane peroxidizability index is inversely related to maximum life span in mammals. J Lipid Res 39:1989-1994
37. Evans JL, Goldfme ID, Maddux BA, Grodsky GM (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622
38. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV (1993) The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328:238-244
39. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40:280-289
40. Vessby B, Unsitupa M, Hermansen K et al (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia 44:312-319
41. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467
42. Drucker DJ (2003) Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26:2929-2940
43. Rocca AS, LaGreca J, Kalitsky J, Brubaker PL (2001) Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology 142:1148-1155
44. Xiao Q, Boushey RP, Drucker DJ, Brubaker PL (1999) Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology 117:99-105
45. Wiesenthal SR, Sandhu H, McCall RH et al (1999) Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48:766-774
46. Bergman RN (2002) Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. Mt Sinai J Med 69:280-290
47. Paolisso G, Gambardella A, Amato L et al (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295-1299